Home
Browse Guidelines
Expert Commentaries
Guideline Syntheses
Guideline Matrix
Guideline Resources
Compare Guidelines
Frequently Asked Questions
Submit Guidelines
About
myNGC

Announcements

April 09, 2012

Health Awareness Topics - April 2012



How to Participate


  • Submit guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.
  • Suggest a guideline for possible inclusion: Submit your suggestions for evidence-based guidelines that you would like to see included in NGC.
  • Suggest a Guideline Synthesis topic: We welcome your suggestions for guideline synthesis topics!

Conference News


The Guidelines International Network (G-I-N) Conference 2012, will be held August 22-25, 2012 in Berlin, Germany. Registration External Web Site Policy is now open.

U.S. Food and Drug Administration (FDA) Advisory


  • April 10, 2012: Birth Control Pills Containing Drospirenone External Web Site Policy: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills. FDA is adding information about the studies to the labels of drospirenone-containing birth control pills.

NGC's Sister Resources